REGN1033 (SAR391786)

REGN1033 · Regeneron Pharmaceuticals

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for REGN1033 (SAR391786), covering 2013-09-12 to 2016-03-28. Get the full timeline:

Most recent: Clinical Trial Update: Study of the Safety and Efficacy of REGN1033 (SAR391786) in Patients With Sarcopenia [Phase 2]